Feasibility of Fabric Orthosis for Knee Support in Elderly Gait Improvement
Safety and Feasibility of Knee Extensor Muscle-mimicking, Fabric-type Orthosis on Gait in Geriatric Patients: Pilot Clinical Trial
1 other identifier
interventional
30
1 country
1
Brief Summary
This pilot clinical trial assesses the safety and feasibility of a novel fabric-type orthosis designed to mimic the knee extensor muscles and improve gait in elderly patients with mobility impairments due to conditions like sarcopenia, diabetes, or knee osteoarthritis. The study aims to test this orthosis in a real- world setting to see if it can enhance mobility and stability for elderly individuals, potentially reducing falls and improving quality of life. A total of 30 participants aged 65 and older will be recruited to use this orthosis across multiple sessions, where their gait will be analyzed under various conditions to measure the device's impact on walking speed, stability, and muscle activation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 22, 2024
CompletedFirst Posted
Study publicly available on registry
April 29, 2024
CompletedStudy Start
First participant enrolled
July 31, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 14, 2026
ExpectedJune 11, 2025
July 1, 2024
12 months
April 22, 2024
June 8, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Completion Rate
The proportion of participants who complete the study as per the protocol, which indicates the orthosis's acceptability and the study's overall manageability.
1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Secondary Outcomes (6)
Dropout Rate
1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
User Feedback
1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
6-Minute Walk Test
1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
10-Meter Walk Test
1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Surface Electromyography
1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
- +1 more secondary outcomes
Study Arms (1)
Knee Extensor Muscle-Mimicking Orthosis
EXPERIMENTALThis arm involves participants wearing a novel, lightweight fabric-type orthosis designed to mimic the function of knee extensor muscles through embedded shape-memory alloys. This intervention aims to support the knee joint during gait, enhancing stability and mobility for elderly individuals with compromised muscle function.
Interventions
The intervention device is a fabric-based orthosis incorporating shape-memory alloy springs designed to mimic the action of knee extensor muscles. The primary function of this orthosis is to provide supplementary support to the knee joint during walking, aiming to stabilize the gait of elderly individuals affected by muscle weakness or degenerative joint conditions. Material: The orthosis is made from a lightweight, flexible fabric that allows for breathability and comfort during extended wear. Mechanism: Embedded within the fabric are shape- memory alloy springs that function similarly to biological muscles.
Eligibility Criteria
You may qualify if:
- Eligibility for participation in the study requires that all the following criteria are met:
- Age: Participants must be 65 years of age or older.
- Comprehension and Compliance: Able to fully understand and comply with the instructions and study procedures.
- Mobility-Impacting Conditions: Must have at least one of the following conditions affecting mobility: (1)Sarcopenia:
- Muscle Strength: Handgrip strength of \<28 kg for men and \<18 kg for women.
- Muscle Function: Short Physical Performance Battery (SPPB) score of 8 or less.
- Muscle Mass: Bioelectrical impedance analysis (BIA) showing muscle mass \<7.0 kg/m² for men and \<5.7 kg/m² for women. (2)Diabetes:
- Diagnosed distal symmetric polyneuropathy.
- Sensory impairments in toes or feet. (3)Knee Osteoarthritis:
- Kellgren-Lawrence grade ≥2.
- Persistent pain (≥3 months) with a severity of at least 3 on the Numerical Rating Scale (NRS).
You may not qualify if:
- Individuals meeting any of the following criteria will be excluded from study participation:
- Inability to Consent: Unable to provide informed consent or not willing to participate in the study procedures.
- Severe Sensory or Motion Limitations: Including severe visual or vestibular impairments that could increase the risk of falling.
- Communication Barriers: Significant hearing, speech, or language problems that would hinder communication with study personnel.
- Independent Walking Inability: Cannot walk independently without the aid of a walking device.
- Other Significant Diseases or Conditions:
- Neurological disorders that affect walking ability (e.g., stroke, Parkinson's disease).
- Orthopedic or musculoskeletal conditions severely affecting lower limb function.
- Severe cardiovascular conditions including uncontrolled hypertension or heart failure.
- Respiratory diseases requiring regular oxygen therapy.
- Active cancer treatment or cancer treatment within the past 3 years (except basal cell carcinoma or localized prostate cancer).
- Severe psychiatric disorders like schizophrenia or bipolar disorder.
- Past severe orthopedic surgeries on lower limbs which might affect gait and mobility.
- Severe back pain or any other condition affecting mobility not already listed.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Seoul National University Hospital
Seoul, Jongno, 03080, South Korea
Study Officials
- PRINCIPAL INVESTIGATOR
hyungik shin, prof
Seoul National University Hospital
- STUDY DIRECTOR
Woo Hyung Lee, prof
Seoul National University Hospital
- STUDY DIRECTOR
Jung hyun Kim, prof
Seoul National University Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 22, 2024
First Posted
April 29, 2024
Study Start
July 31, 2024
Primary Completion
July 30, 2025
Study Completion (Estimated)
May 14, 2026
Last Updated
June 11, 2025
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share